ProNAi Therapeutics Raises $59.5 Million Series D Financing
PLYMOUTH - ProNAi Therapeutics has closed an oversubscribed $59.5 million Series D financing, led by Vivo Capital of Palo Alto, CA and included other new investors Frazier Healthcare Ventures, OrbiMed Advisors, Adams Street Partners, RA Capital Management, Caxton Alternative Management, Hopen Life Science Ventures, Sectoral Asset Management, and Janus Capital Management LLC. Existing investors including